APO-ZIDOVUDINE-LAMIVUDINE-NEVIRAPINE
APO-ZIDOVUDINE-LAMIVUDINE-NEVIRAPINE
Approved
DIN Number
02281368
Drug Class
Human
Market Date
N/A
Company
HC
Apotex Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02281368
AIG Number0351645001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AR05 ZIDOVUDINE, LAMIVUDINE AND NEVIRAPINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.08.16
Health Canada Classification
ACTIVE INGREDIENTS (3)
LAMIVUDINEActive
Strength: 150 MG
Monograph: LAMIVUDINE
NEVIRAPINEActive
Strength: 200 MG
Monograph: NEVIRAPINE
ZIDOVUDINEActive
Strength: 300 MG
Monograph: ZIDOVUDINE